Teva Pharmaceutical Industries Limited
TEVJF
$37.00
$8.6030.28%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.66B | 3.74B | 3.56B | 2.20B | 2.16B |
| Total Receivables | 3.49B | 3.39B | 3.71B | 3.81B | 3.56B |
| Inventory | 3.22B | 3.18B | 3.18B | 3.32B | 3.50B |
| Prepaid Expenses | 1.03B | 1.07B | 1.12B | 1.12B | 1.08B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.36B | 2.33B | 2.38B | 2.29B | 2.31B |
| Total Current Assets | 13.76B | 13.71B | 13.95B | 12.74B | 12.62B |
|
|
|||||
| Total Current Assets | 13.76B | 13.71B | 13.95B | 12.74B | 12.62B |
| Net Property, Plant & Equipment | 4.26B | 4.33B | 4.43B | 5.16B | 5.17B |
| Long-term Investments | 15.84B | 15.82B | 16.00B | 15.95B | 15.95B |
| Goodwill | 15.84B | 15.82B | 16.00B | 15.95B | 15.95B |
| Total Other Intangibles | 3.45B | 3.61B | 3.78B | 3.94B | 4.14B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.55B | 2.57B | 2.60B | 2.08B | 2.25B |
| Total Assets | 39.86B | 40.04B | 40.75B | 39.86B | 40.13B |
|
|
|||||
| Total Accounts Payable | 2.72B | 2.60B | 2.53B | 2.36B | 2.50B |
| Total Accrued Expenses | 5.70B | 5.51B | 6.08B | 6.22B | 6.05B |
| Short-term Debt | -- | 12.00M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.50B | 2.60B | 1.91B | 24.00M | 464.00M |
| Total Finance Division Other Current Liabilities | 2.72B | 2.81B | 2.93B | 2.89B | 2.85B |
| Total Other Current Liabilities | 2.72B | 2.81B | 2.93B | 2.89B | 2.85B |
| Total Current Liabilities | 15.65B | 13.53B | 13.46B | 11.49B | 11.86B |
|
|
|||||
| Total Current Liabilities | 15.65B | 13.53B | 13.46B | 11.49B | 11.86B |
| Long-Term Debt | 12.11B | 14.03B | 15.01B | 16.78B | 16.78B |
| Short-term Debt | -- | 12.00M | -- | -- | -- |
| Capital Leases | 282.00M | 280.00M | 311.00M | 283.00M | 296.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.06B | 3.96B | 4.06B | 4.04B | 4.36B |
| Total Liabilities | 32.10B | 31.81B | 32.83B | 32.60B | 33.30B |
|
|
|||||
| Common Stock & APIC | 28.32B | 28.26B | 28.19B | 28.10B | 28.06B |
| Retained Earnings | -13.97B | -13.39B | -13.76B | -14.24B | -14.68B |
| Treasury Stock & Other | -6.59B | -6.64B | -6.52B | -6.60B | -6.56B |
| Total Common Equity | 7.75B | 8.23B | 7.91B | 7.25B | 6.83B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.75B | 8.23B | 7.91B | 7.25B | 6.83B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 4.00M | 4.00M | 4.00M | 4.00M | 7.00M |
| Total Equity | 7.76B | 8.23B | 7.91B | 7.25B | 6.83B |
|
|
|||||